Clinical And Experimental Medicine SCIE

國(guó)際簡(jiǎn)稱：CLIN EXP MED 參考譯名：臨床和實(shí)驗(yàn)醫(yī)學(xué)

主要研究方向：醫(yī)學(xué)-醫(yī)學(xué)：研究與實(shí)驗(yàn) 非預(yù)警期刊審稿周期：約2.5月

《臨床和實(shí)驗(yàn)醫(yī)學(xué)》(Clinical And Experimental Medicine)是一本由Springer International Publishing出版的以醫(yī)學(xué)-醫(yī)學(xué)：研究與實(shí)驗(yàn)為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開(kāi)放期刊，近三年沒(méi)有被列入預(yù)警名單。

4區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
246 年發(fā)文量
3.2 IF影響因子
未開(kāi)放 是否OA
39 H-index
2001 創(chuàng)刊年份
Quarterly 出版周期
English 出版語(yǔ)言

Clinical and Experimental Medicine (CEM) is a multidisciplinary journal that aims to be a forum of scientific excellence and information exchange in relation to the basic and clinical features of the following fields: hematology, onco-hematology, oncology, virology, immunology, and rheumatology. The journal publishes reviews and editorials, experimental and preclinical studies, translational research, prospectively designed clinical trials, and epidemiological studies. Papers containing new clinical or experimental data that are likely to contribute to changes in clinical practice or the way in which a disease is thought about will be given priority due to their immediate importance. Case reports will be accepted on an exceptional basis only, and their submission is discouraged. The major criteria for publication are clarity, scientific soundness, and advances in knowledge. In compliance with the overwhelmingly prevailing request by the international scientific community, and with respect for eco-compatibility issues, CEM is now published exclusively online.

[ 查看全部 ]

投稿咨詢加急咨詢

Clinical And Experimental Medicine期刊信息

ISSN：1591-8890
出版語(yǔ)言：English
是否OA：未開(kāi)放
E-ISSN：1591-9528
出版地區(qū)：ITALY
是否預(yù)警：否
出版商：Springer International Publishing
出版周期：Quarterly
創(chuàng)刊時(shí)間：2001
開(kāi)源占比：0.2075
Gold OA文章占比：27.58%
OA被引用占比：0.1036...
出版國(guó)人文章占比：0.34
出版撤稿占比：0
研究類(lèi)文章占比：67.07%

Clinical And Experimental Medicine CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

4.8

1.038

1.145

學(xué)科類(lèi)別	分區(qū)	排名	百分位
大類(lèi)：Biochemistry, Genetics and Molecular Biology 小類(lèi)：General Biochemistry, Genetics and Molecular Biology	Q2	81 / 221	63%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類(lèi)型包括：文章、評(píng)論、會(huì)議論文、書(shū)籍章節(jié)和數(shù)據(jù)論文。

Clinical And Experimental Medicine中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類(lèi)學(xué)科		小類(lèi)學(xué)科
否	否	醫(yī)學(xué)	4區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	4區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類(lèi)學(xué)科		小類(lèi)學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	3區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類(lèi)學(xué)科		小類(lèi)學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	3區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類(lèi)學(xué)科		小類(lèi)學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	4區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類(lèi)學(xué)科		小類(lèi)學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	3區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類(lèi)學(xué)科		小類(lèi)學(xué)科
否	否	醫(yī)學(xué)	4區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	4區(qū)

Clinical And Experimental Medicine JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	81 / 189	57.4%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	84 / 189	55.82%

Clinical And Experimental Medicine歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Clinical And Experimental Medicine中國(guó)學(xué)者發(fā)文選摘

1、In vivo antitumor efficacy of 17-AAG loaded PMMA in a human multiple myeloma xenograft mouse model
Author: Shi, Xiangjun; Wei, Yanzhe; Yao, Xingchen; Du, Boran; Wu, Xiaoguang; Kong, Xiangyu; Du, Xinru

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. 23, Issue 1, pp. 45-54. DOI: 10.1007/s10238-021-00786-w
2、Prognostic value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography at diagnosis in untreated multiple myeloma patients: a systematic review and meta-analysis
Author: Li, Qian; Hu, Linhui; Charwudzi, Alice; Zhu, Weiwei; Meng, Ye; Zhai, Zhimin

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. 23, Issue 1, pp. 31-43. DOI: 10.1007/s10238-021-00775-z
3、A study of the prognostic value of long non-coding RNA CASC15 in human solid tumors utilizing The Cancer Genome Atlas (TCGA) datasets and a meta-analysis
Author: Chen, Weiwei; Qian, Wenqi; Nie, Jun; Dai, Mintao

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. 23, Issue 1, pp. 65-78. DOI: 10.1007/s10238-021-00789-7
4、Immunohistochemical evaluation and prognostic value of monocarboxylate transporter 1 (MCT1) and 4 (MCT4) in T-cell non-Hodgkin lymphoma
Author: Zhao, Hu; Chen, Yuan; Liao, You-Ping; Chen, Hai-Mei; Yang, Qiu-Hong; Xiao, Yin; Luo, Jing; Chen, Zhen-Zhen; Yi, Lai; Hu, Guo-Yu

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. 23, Issue 1, pp. 55-64. DOI: 10.1007/s10238-022-00805-4
5、Influence of AFP on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma
Author: Tan, Xiao-ping; Zhou, Kai; Zeng, Qing-li; Yuan, Yun-fei; Chen, Wei

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. 23, Issue 1, pp. 107-115. DOI: 10.1007/s10238-022-00813-4
6、Distribution and survival outcomes of primary head and neck hematolymphoid neoplasms in older people: a population-based study
Author: Zheng, Yan-Hua; Tian, Biao; Qin, Wei-Wei; Zhu, Qing-Wen; Feng, Juan; Hu, Wu-Yue; Chen, Ren-An; Liu, Li

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10238-023-01069-2
7、Ubiquitin-specific peptidase 1: assessing its role in cancer therapy
Author: Huang, Peng; Wang, YuHan; Zhang, PengFei; Li, Qiu

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10238-023-01075-4
8、Superoxide dismutase 2 as a predictor in patients with hepatitis B virus-associated acute-on-chronic liver failure
Author: Liu, Huihui; Lyu, Hui; Jiang, Xuemei; Wang, Li; Li, Haiming; Wei, Xuefei; Li, Linlin; Zhu, Jinyu; Fan, Yuchen; Wang, Kai

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10238-022-00979-x